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In the past few years, there has been renewed interest in the use of thresholds for declaring statistical 
significance and, if we decide to use thresholds, what alpha value is optimal. Should we lower the 
threshold for claiming statistical significance from p < .05 to p < .0051? Should we justify the selected 
alpha level for every study separately2? Or should we abandon statistical significance altogether3? 
Whilst these proposals may appear at odds, they align in terms of their goal—to improve the 
robustness of our inferences. However, empirical data that sheds light on the potential costs and 
benefits of these approaches remains scarce.  
 
Koletsi and colleagues4 attempt to address this issue. They focus on the first proposal—reducing the 
threshold for declaring statistical significance from p < .05 to p < .005—and provide empirical evidence 
for the impact of doing so. They show that lowering the statistical significance threshold in meta-
analyses of clinical interventions would not substantially reduce the number of true discoveries. In 
their sample, only 2.9% (95% CI 0.4-10%) of recommended interventions would be disregarded (i.e., 
incorrectly excluded) if the more stringent p < .005 threshold was applied, whilst 39% (95% CI 24-57%) 
of interventions that have some statistical evidence (i.e., p < 0.05) but are currently recommended 
against or not recommended for other reasons would be disregarded (i.e., correctly excluded). In other 
words, the benefits of lowering the threshold for claiming statistical significance in meta-analyses of 
clinical interventions outweigh the costs.  
 
This study forms part of a growing literature investigating the research process itself (sometimes 
described as meta-research, or research on research). In an ideal world, researchers would iteratively 
identify and investigate problems in the research process, develop potential solutions, and evaluate 
these5. This approach has the potential to provide a background process of continual improvement in 
how we work. Elements of this approach are certainly not new. Researchers have identified 
shortcomings in the use of statistical inference in published research for at least a half century, 
investigated them more thoroughly over the past decade or two, and recently suggested a range of 
potential solutions (e.g., 1–3). What remains scarce, however, is the evaluation of potential solutions. 
Koletsi and colleagues address this gap.  
 
The evaluation step of meta-research provides the empirical evidence necessary to justify changes we 
might wish to make to the research ecosystem. For example, meta-research studies have shown how 
journal data sharing policies may increase data availability, but leave the usability of the shared data 
 
 
low6, that reporting checklists may not actually improve compliance with guidelines7, and that 
preregistration of study protocols might allow questionable research practices to be more readily 
identified, but does not always reduce these practices8. Each of these studies evaluates a specific 
implementation of a proposed solution or improvement. Without this evidence, we would be left to 
simply implement what seem like good ideas (but may not be in practice). And that is clearly 
inadequate. 
  
Koletsi and colleagues focus on a specific proposed statistical reform in the context of meta-analyses 
and clinical practice recommendations: reducing the threshold for claiming statistical significance. In 
some cases, such as when deciding whether or not to recommend a clinical intervention, dichotomous 
inference may be necessary. In this context, the results presented by Koletsi and colleagues provide 
support for a pragmatic revision of the conventional alpha level, from 0.05 to 0.005. The data show, 
however, that relying solely on a revised alpha level is no panacea: 15% (95% CI 7-25%) of 
recommended interventions are lost to the revised threshold and 24% (95% CI 16-33%) of the 
interventions that meet the revised threshold are either recommended against or not recommended.  
 
Crucially, Koletsi and colleagues only arrive at their minimal cost of a 2.9% reduction in recommended 
interventions by going beyond a strict statistical threshold and considering additional factors. This 
(perhaps ironically) illustrates that, for many research questions, the dichotomisation of statistical 
evidence is simply too crude an approach, at least on its own. Koletsi and colleagues are in effect 
combining proposed solutions: they are using alpha values to dichotomise the evidence and then 
drawing on additional information for borderline decisions. 
 
We can also improve our statistical inferences through other initiatives largely independent of how 
we define and use statistical thresholds. Preregistering hypotheses and analysis plans can safeguard 
against selective reporting and p-hacking—or at least provide the evidence to demonstrate when 
these practices have not been done. The Registered Reports submission format offered by many 
journals allows for peer-review of methods before conducting the research9. This places peer review 
earlier in the research process than is usual, and at a stage where it can impact the design of a study, 
not just the reporting. Open research practices such as sharing data, analysis code, and research 
materials can also provide transparency, greater checking, and perhaps improved quality control. 
 
The conversation on improving research practices has thus far focused largely on the epidemiology of 
the problem—what are the factors that contribute to poor quality research. We are now seeing 
research into how to make the transition to better research practice—what are the interventions, how 
can we implement them, and what is the evidence that they work. This effort requires coordination 
among stakeholders across the research landscape: funders, publishers, institutions, policy makers, 
and researchers10. An investment in research that evaluates solutions and studies how best to 
implement them will allow for iterative improvements in how we do research, and will return that 




We calculated the four confidence intervals reported in this commentary using the R code 
binom.test(x, n, alternative="two.sided", conf.level=0.95) where x and n come from the Primary 




Koletsi and colleagues coded intervention recommendations based on information available on 
UpToDate—a point-of-care medical resources that provides recommendations for clinical practice11. 
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